Evaluation of Plasminogen and other Fibrinolytic Parameters in the Amniotic Fluid

Thromb Haemost 1980; 43(02): 182
DOI: 10.1055/s-0038-1650045

Letter to the Editor

Schattauer GmbH Stuttgart

J Aznar

Department of Clinical Pathology, Department of Obstetrics and Gynecology and Research Center, Ciudad Sanitaria "La Fe". Valencia. Spain

,

J Gilabert

Department of Clinical Pathology, Department of Obstetrics and Gynecology and Research Center, Ciudad Sanitaria "La Fe". Valencia. Spain

,

A Estelles

Department of Clinical Pathology, Department of Obstetrics and Gynecology and Research Center, Ciudad Sanitaria "La Fe". Valencia. Spain

,

J J Parrilla

Department of Clinical Pathology, Department of Obstetrics and Gynecology and Research Center, Ciudad Sanitaria "La Fe". Valencia. Spain

References
1 Aznar J, Hernandez A, Parrilla JJ, Estelles A, Gilabert J. Changes in human amniotic fluid fibrinolytic inhibitors levels during pregnancy. Thrombos Haemost 1976; 35: 382-385
2 Wu KK, Jacobsen CD, Hoak JC. Highly sensitive method for the assay of plasminogen. J Lab Clin Med 1973; 81: 484-488
3 Merskey C, Lalezary P, Johnson AJ. A rapid method for measuring fibrinogen split products in human serum. Proc Soc Exp Biol Med 1969; 131: 871-875
4 Aoki N, von Kaulla RN. Inactivation of human serum plasminogen antiactivator by synthetic fibrinolysis inducers. Thrombos Diath Haemorrh 1969; 22: 251-262
5 Hawkey CM, Stafford JL. A standard clot method for assay of plasminogen activator antiactivators and plasmin. J Clin Pathol 1964; 17: 175-181
6 Phillips LL, Davidson EC. Procoagulant properties of amniotic fluid. Am J Obstet Gynecol 1972; 113: 911-919